COMPLEMENT COMPONENT C4 - ANVISA Registration 80146502193

Access comprehensive regulatory information for COMPLEMENT COMPONENT C4 in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502193 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including THE BINDING SITE GROUP LTD, BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.